General Information of the Cell Line
Cell Line ID
CL000211
Cell Line Name
Ishikawa
Synonyms
ISHIKAWA
ISHI
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_2529
Tissue Information
Endometrium
Disease
Endometrial adenocarcinoma (NCIt: C7359)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00886, Estrogen receptor
Compound ID Compound Name Compound Formula
CP0206927
(8R,9S,13S,14S,17S)-13-methyl-17-prop-1-ynyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
   Show/Hide
C21H26O2
 1
1
EC50 = 0.028 nM
   TI
   LI
   LO
   TS
CP0006292
(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-triene-5,14-diol
   Show/Hide
C18H24O2
 1
1
EC50 = 0.03 nM
   TI
   LI
   LO
   TS
CP0062959
PROPYLPYRAZOLETRIOL
   Show/Hide
C24H22N2O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0450628
(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
   Show/Hide
C20H20O5
 1
1
EC50 = 5 nM
   TI
   LI
   LO
   TS
CP0430581
17alpha-(4-Aminophenyl)ethynyl-estra-1,3,5(10)-triene-3,17b-diol
   Show/Hide
C26H29NO2
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0309585
17alpha-(17-1,2,3-Triazolmethyl)ethynyl-estra-1,3,5(10)-triene-3,17b-diol
   Show/Hide
C21H27N3O2
 1
1
EC50 = 27 nM
   TI
   LI
   LO
   TS
CP0450384
17alpha-[(4-Hydroxymethylphenyl)]ethynyl-estra-1,3,5-(10)-triene-3,17beta-diol
   Show/Hide
C27H30O3
 1
1
EC50 = 27 nM
   TI
   LI
   LO
   TS
CP0401808
5,7-Dihydroxy-2-(4-hydroxy-phenyl)-8-(3-methyl-but-2-enyl)-chromen-4-one
   Show/Hide
C20H18O5
 1
1
EC50 = 50 nM
   TI
   LI
   LO
   TS
CP0062960
(+/-)-2,3-bis(4-hydroxyphenyl)propanenitrile
   Show/Hide
C15H13NO2
 1
1
EC50 = 80 nM
   TI
   LI
   LO
   TS
CP0038801
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5-[2-[4-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]triazol-1-yl]ethyl]-10,15,20,25,30,35-hexakis[[4-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]triazol-1-yl]methyl]-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol
   Show/Hide
C183H233N21O42
 1
1
EC50 = 200 nM
   TI
   LI
   LO
   TS
CP0012708
5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
   Show/Hide
C15H10O5
 1
1
EC50 = 240 nM
   TI
   LI
   LO
   TS
CP0336102
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-heptakis[[[4-[2-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methylamino]methyl]-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol
   Show/Hide
C231H273N7O42
 1
1
EC50 = 300 nM
   TI
   LI
   LO
   TS
CP0526897
16-(4-{[(1-{3-[fluoro(methoxy)phosphoryl]propyl}-1H-1,2,3-triazol-4-yl)methyl]sulfamoyl}-2-(hydroxysulfinato)phenyl)-3-oxa-9,23-diazaheptacyclo[17.7.1.1^{5,9}.0^{2,17}.0^{4,15}.0^{23,27}.0^{13,28}]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-9-ylium
   Show/Hide
C350H402N32O60
 1
1
EC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0887302
(1S,10R,11S,14S,15S)-14-(1-{[(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-20-(2-{4-[(1S,10R,11S,14S,15S)-5-({2-[3,6-bis(ethylamino)-2,7-dimethyl-9,10-dihydroanthracen-9-yl]phenyl}carbonyloxy)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-yl]-1H-1,2,3-triazol-1-yl}ethyl)-15,25,30,35-tetrakis({4-[(1S,10R,11S,14S,15S)-5-({2-[3,6-bis(ethylamino)-2,7-dimethyl-9,10-dihydroanthracen-9-yl]phenyl}carbonyloxy)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-yl]-1H-1,2,3-triazol-1-yl}methyl)-10-({4-[(1S,10R,11S,14S,15S)-5-({2-[6-(ethylamino)-3-[(E)-2-(ethylamino)ethenyl]-7-methyl-2-(2-methylprop-1-en-1-yl)-1,4-dihydronaphthalen-1-yl]phenyl}carbonyloxy)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-yl]-1H-1,2,3-triazol-1-yl}methyl)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2^{3,6}.2^{8,11}.2^{13,16}.2^{18,21}.2^{23,26}.2^{28,31}]nonatetracontan-5-yl]methyl}-1H-1,2,3-triazol-4-yl)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-5-yl 2-[3,6-bis(ethylamino)-2,7-dimethyl-9,10-dihydroanthracen-9-yl]benzoate
   Show/Hide
C373H433N35O49
 1
1
EC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0309586
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5-[[4-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]triazol-1-yl]methyl]-10,15,20,25,30,35-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol
   Show/Hide
C62H93N3O36
 1
1
EC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0337106
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5-[[[4-[2-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methylamino]methyl]-10,15,20,25,30,35-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol
   Show/Hide
C69H99NO36
 1
1
EC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0150847
(R)-5-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H31NO5
 1
1
IC50 = 0.2 nM
   TI
   LI
   LO
   TS
CP0317549
19-[4-(2-piperidin-1-ylethoxy)phenyl]-8,18-dioxatetracyclo[9.8.0.02,7.012,17]nonadeca-1(11),2(7),3,5,12(17),13,15-heptaene-5,15-diol
   Show/Hide
C30H31NO5
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0074206
(R)-5-[4-(2-Pyrrolidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO5
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0041761
2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol
   Show/Hide
C28H27NO4S
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0264843
(S)-5-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C30H31NO4
 1
1
IC50 = 25.9 nM
   TI
   LI
   LO
   TS
CP0307559
(S)-8-Methoxy-5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C31H33NO5
 1
1
IC50 = 25.9 nM
   TI
   LI
   LO
   TS
CP0149126
(S)-5-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H31NO5
 1
1
IC50 = 32 nM
   TI
   LI
   LO
   TS
CP0271994
5S-(-)-[4-(2-diisopropylaminoethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta-[1,2-a]naphthalene-2,8-diol
   Show/Hide
C31H35NO5
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0204168
(R)-5-[4-(2-Azepan-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C31H33NO5
 1
1
IC50 = 41 nM
   TI
   LI
   LO
   TS
CP0352779
(R)-5-[4-(2-Morpholin-4-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO6
 1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
CP0149030
(R)-5-[4-(2-Dimethylamino-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C27H27NO5
 1
1
IC50 = 61 nM
   TI
   LI
   LO
   TS
CP0315839
5S-(-)-[4-(2-azepan-1-ylethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C31H33NO4
 1
1
IC50 = 68 nM
   TI
   LI
   LO
   TS
CP0149117
(R)-2-Methoxy-5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C31H33NO5
 1
1
IC50 = 76 nM
   TI
   LI
   LO
   TS
CP0317079
5R-[4-(2-piperidin-1-ylethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C30H31NO4
 1
1
IC50 = 76 nM
   TI
   LI
   LO
   TS
CP0236096
(R)-5-[4-(2-Azepan-1-yl-ethoxy)-phenyl]-8-fluoro-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C31H32FNO4
 1
1
IC50 = 81 nM
   TI
   LI
   LO
   TS
CP0265682
(R)-5-[4-(2-Thiomorpholin-4-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO5S
 1
1
IC50 = 87 nM
   TI
   LI
   LO
   TS
CP0271991
(R)-5-{4-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-phenyl}-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H32N2O5
 1
1
IC50 = 90 nM
   TI
   LI
   LO
   TS
CP0151313
5R-(+)-[4-(2-diethylaminoethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C29H31NO4
 1
1
IC50 = 113 nM
   TI
   LI
   LO
   TS
CP0271992
(R)-5-[4-(2-Diethylamino-ethoxy)-phenyl]-8-fluoro-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C29H30FNO4
 1
1
IC50 = 113 nM
   TI
   LI
   LO
   TS
CP0096802
20-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-8,19-dioxatetracyclo[10.8.0.0^{2,7}.0^{13,18}]icosa-1(12),2(7),3,5,13,15,17-heptaene-5,16-diol
   Show/Hide
C31H33NO5
 1
1
IC50 = 121 nM
   TI
   LI
   LO
   TS
CP0165906
(S)-5-[4-(2-Diethylamino-ethoxy)-phenyl]-8-fluoro-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C29H30FNO4
 1
1
IC50 = 122 nM
   TI
   LI
   LO
   TS
CP0271993
(S)-5-[4-(2-Azepan-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C31H33NO5
 1
1
IC50 = 128 nM
   TI
   LI
   LO
   TS
CP0306439
5S-(-)-[4-(2-diethylaminoethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo-[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C29H31NO4
 1
1
IC50 = 133 nM
   TI
   LI
   LO
   TS
CP0149115
5R-(+)-[4-(2-dimethylaminoethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C27H27NO4
 1
1
IC50 = 134 nM
   TI
   LI
   LO
   TS
CP0274537
5S-(-)-[4-(2-azepan-1-ylethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C31H33NO4
 1
1
IC50 = 144 nM
   TI
   LI
   LO
   TS
CP0181776
5S-(+)-[4-(2-piperidin-1-ylethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C30H31NO4
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0265683
(S)-2-Methoxy-5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C31H33NO5
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0271989
5S-(-)-[4-(2-Dimethylamino-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa benzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C27H27NO4
 1
1
IC50 = 158 nM
   TI
   LI
   LO
   TS
CP0274557
(S)-5-[4-(2-Azepan-1-yl-ethoxy)-phenyl]-8-fluoro-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C31H32FNO4
 1
1
IC50 = 161 nM
   TI
   LI
   LO
   TS
CP0271988
(S)-5-[4-(2-Pyrrolidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO5
 1
1
IC50 = 165 nM
   TI
   LI
   LO
   TS
CP0191133
5S-(-)-[4-(2-dimethylaminoethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C27H27NO4
 1
1
IC50 = 194 nM
   TI
   LI
   LO
   TS
CP0264844
(R)-8-Methoxy-5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C31H33NO5
 1
1
IC50 = 259 nM
   TI
   LI
   LO
   TS
CP0307562
(R)-5-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C30H31NO4
 1
1
IC50 = 259 nM
   TI
   LI
   LO
   TS
CP0165902
5R-(+)-[4-(2-diisopropylaminoethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C31H35NO5
 1
1
IC50 = 287 nM
   TI
   LI
   LO
   TS
CP0181777
5R-(+)-[4-(2-azepan-1-ylethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-2-ol
   Show/Hide
C31H33NO4
 1
1
IC50 = 293 nM
   TI
   LI
   LO
   TS
CP0149118
(S)-5-[4-(2-Dimethylamino-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C27H27NO5
 1
1
IC50 = 405 nM
   TI
   LI
   LO
   TS
CP0149119
(R)-5-[4-(3-Piperidin-1-yl-propoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C31H33NO5
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0149026
(S)-5-[4-(3-Piperidin-1-yl-propoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C31H33NO5
 1
1
IC50 = 590 nM
   TI
   LI
   LO
   TS
CP0045844
1-{2-[4-((R)-2,8-Dimethoxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-ethyl}-piperidine
   Show/Hide
C32H35NO5
 1
1
IC50 = 1736 nM
   TI
   LI
   LO
   TS
CP0264845
5R-(+)-[4-(2-azepan-1-ylethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C31H33NO4
 1
1
IC50 = 2670 nM
   TI
   LI
   LO
   TS
CP0265684
5R-(+)-[4-(2-Dimethylamino-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalen-8-ol
   Show/Hide
C27H27NO4
 1
1
IC50 = 8990 nM
   TI
   LI
   LO
   TS
CP0045959
1-{2-[4-((S)-2,8-Dihydroxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-ethyl}-pyrrolidine-2,5-dione
   Show/Hide
C29H25NO7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0074060
5S-[3-(2-Thiomorpholin-4-ylethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO5S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0074205
(S)-5-[3-(2-Piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H31NO5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0149031
methyl 2-[4-(5,15-dihydroxy-8,18-dioxatetracyclo[9.8.0.02,7.012,17]nonadeca-1(11),2(7),3,5,12(17),13,15-heptaen-19-yl)phenoxy]acetate
   Show/Hide
C26H22O7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0150784
(S)-5-[4-(2-Morpholin-4-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0151315
1-{2-[4-((R)-2,8-Dihydroxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-ethyl}-pyrrolidine-2,5-dione
   Show/Hide
C29H25NO7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0165904
(S)-5-{4-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-phenyl}-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H32N2O5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0181778
(S)-5-{3-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-phenyl}-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H32N2O5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0264846
(R)-5-[3-(2-Piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H31NO5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0264848
5-[4-(3-Hydroxypropoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthal ene-2,8-diol
   Show/Hide
C26H24O6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0264850
1-{2-[4-((S)-2,8-Dimethoxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-ethyl}-piperidine
   Show/Hide
C32H35NO5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0271990
3-[4-((S)-2,8-Dihydroxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-propionic acid
   Show/Hide
C26H22O7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0271995
1-{3-[4-((S)-2,8-Dihydroxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-propyl}-pyrrolidine-2,5-dione
   Show/Hide
C30H27NO7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0271996
(R)-5-[3-(2-Thiomorpholin-4-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO5S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0272307
(R)-5-{3-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-phenyl}-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C30H32N2O5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0274555
3-[4-((R)-2,8-Dihydroxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-propionic acid
   Show/Hide
C26H22O7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0274556
1-{3-[4-((R)-2,8-Dihydroxy-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalen-5-yl)-phenoxy]-propyl}-pyrrolidine-2,5-dione
   Show/Hide
C30H27NO7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0314443
5-[4-(2-Hydroxyethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta [1,2-a]naphthalene-2,8-diol
   Show/Hide
C25H22O6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0314444
(S)-5-[4-(2-Thiomorpholin-4-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol
   Show/Hide
C29H29NO5S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0450628
(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
   Show/Hide
C20H20O5  1
1
IC50 = 19100 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Endometrium)
Cell Line Name Organism Disease
HEC-1 Homo sapiens (Human) Endometrial adenocarcinoma
HEC-1-B Homo sapiens (Human) Endometrial adenocarcinoma